These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
690 related articles for article (PubMed ID: 9418747)
1. The use of newer antidepressants for panic disorder. Gorman JM J Clin Psychiatry; 1997; 58 Suppl 14():54-8; discussion 59. PubMed ID: 9418747 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological treatments in panic disorder in adults: a network meta-analysis. Guaiana G; Meader N; Barbui C; Davies SJ; Furukawa TA; Imai H; Dias S; Caldwell DM; Koesters M; Tajika A; Bighelli I; Pompoli A; Cipriani A; Dawson S; Robertson L Cochrane Database Syst Rev; 2023 Nov; 11(11):CD012729. PubMed ID: 38014714 [TBL] [Abstract][Full Text] [Related]
3. Current concepts in the treatment of panic disorder. Sheehan DV J Clin Psychiatry; 1999; 60 Suppl 18():16-21. PubMed ID: 10487251 [TBL] [Abstract][Full Text] [Related]
4. The role of SSRIs in panic disorder. Sheehan DV; Harnett-Sheehan K J Clin Psychiatry; 1996; 57 Suppl 10():51-8; discussion 59-60. PubMed ID: 8917132 [TBL] [Abstract][Full Text] [Related]
5. Chronic idiopathic urticaria associated with panic disorder: a syndrome responsive to selective serotonin reuptake inhibitor antidepressants? Gupta MA; Gupta AK Cutis; 1995 Jul; 56(1):53-4. PubMed ID: 7555104 [TBL] [Abstract][Full Text] [Related]
6. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis. Bauer M; Tharmanathan P; Volz HP; Moeller HJ; Freemantle N Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):172-85. PubMed ID: 19165525 [TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy of panic disorder: differential efficacy from a clinical viewpoint. den Boer JA J Clin Psychiatry; 1998; 59 Suppl 8():30-6; discussion 37-8. PubMed ID: 9707160 [TBL] [Abstract][Full Text] [Related]
8. Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: a meta-analysis of randomized controlled trials. Einarson TR; Arikian SR; Casciano J; Doyle JJ Clin Ther; 1999 Feb; 21(2):296-308. PubMed ID: 10211533 [TBL] [Abstract][Full Text] [Related]
12. Developments in the drug treatment of panic disorder: what is the place of the selective serotonin reuptake inhibitors? Westenberg HG J Affect Disord; 1996 Sep; 40(1-2):85-93. PubMed ID: 8882918 [TBL] [Abstract][Full Text] [Related]
15. Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2. Ball SE; Ahern D; Scatina J; Kao J Br J Clin Pharmacol; 1997 Jun; 43(6):619-26. PubMed ID: 9205822 [TBL] [Abstract][Full Text] [Related]
16. Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders. Gunasekara NS; Noble S; Benfield P Drugs; 1998 Jan; 55(1):85-120. PubMed ID: 9463792 [TBL] [Abstract][Full Text] [Related]